Bradykinin-induced preconditioning in patients undergoing coronary angioplasty

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 639-650

  Leesar, Massoud A ^a   Stoddard, Marcus F ^a   Manchikalapudi, Srinivas ^a   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; GLYCERYL TRINITRATE;

ADULT; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; VASODILATATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRADYKININ; COLLATERAL CIRCULATION; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 0032835795     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00297-1     Document Type: Article

References (55)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
2. ATP channels, and ischemic preconditioning in dogs. Am J Physiol. 264:1993;H1327-H1336.
3. Cohen M.V., Downey J.M. Preconditioning during ischemia. Cardiol Rev. 3:1995;137-149.
4. Kloner R.A., Bolli R., Marban E., Reinlib L., Braunwald E. Medical and cellular implications of stunning, hibernation and preconditioning an NHLBI workshop . Circulation. 97:1998;1848-1867.
5. Kloner R.A., Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol. 24:1994;1133-1142.
6. Vegh A., Szekeres L., Parratt J.R. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol. 104:1991;294-295.
7. Vegh A., Papp J.G., Szekeres L., Parratt J.R. Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol. 110:1993;18-19.
8. Parratt J.R. Protection of the heart by ischaemic preconditioning mechanisms and possibilities for pharmacological exploitation . Trends Pharmacol Sci. 15:1994;19-25.
9. 2 receptors. Br J Pharmacol. 113:1994;1167-1172.
10. Wall T.M., Sheehy R., Hartman J.C. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther. 270:1994;681-689.
11. Goto M., Liu Y., Yang X.-M., Ardell J.L., Cohen M.V., Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
12. Brew E.C., Mitchell M.B., Rehring T.F., et al. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol. 269:1995;H1370-H1378.
13. 2 receptor activation. J Am Coll Cardiol. 28:1996;1616-1622.
14. Bugge E., Ytrehus K. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol. 28:1996;2333-2341.
15. Matsuki T., Shoji T., Yoshida S., et al. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc Res. 21:1987;428-432.
16. Baumgarten C.R., Linz W., Kunkel G., Schölkens B.A., Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 108:1993;293-295.
17. Martorana P.A., Kettenbach B., Briepohl G., Linz W., Schölkens B.A. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol. 182:1990;395-396.
18. Hartman J.C., Wall T.M., Hullinger T.G., Shebuski R.J. Reduction of myocardial infarct size by ramiprilat reversal by the bradykinin antagonist HOE 140 . J Cardiovasc Pharmacol. 21:1993;996-1003.
19. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
20. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-5.
21. 2 receptor activation in human heart. J Am Coll Cardiol. 29:1997;1599-1606.
22. Indication for ACE inhibitors in the early treatment of acute myocardial infarction systematic overview of individual data from 100,000 patients in randomized trials . Circulation. 97:1998;2202-2212.
23. Brown N.J., Vaughan D.E. Angiotensin-converting enzyme inhibitors. Circulation. 97:1998;1411-1420.
24. Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
25. Effects of captopril on ischemic events after myocardial infarction. Circulation. 90:1994;1731-1738.
26. Kober L., Torp-Pederson C., Carlson J.E., et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
27. Ehring T., Baumgart D., Krajcar M., Hummelgen M., Kompa S., Heusch G. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation. 90:1994;1368-1385.
28. Linz W., Wiemer G., Scholkens B.A. Role of kinins in the pathophysiology of myocardial ischemia in vitro and in vivo studies . Diabetes. 45:(Suppl 1):1996;S51-SS8.
29. Sayer J.W., Timmis A.D. Angiotensin-converting enzyme inhibitors and coronary artery disease. Cardiovasc Drugs Ther. 10:1996;631-637.
30. Deutsch E., Berger M., Kussmaul W.G., Hirshfeld J.W., Herrmann H.C., Laskey W.K. Adaptation to ischemia during percutaneous transluminal coronary angioplasty clinical, hemodynamic, and metabolic features . Circulation. 82:1990;2044-2051.
31. Cribier A., Korsatz L., Koning R., et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty a prospective study . J Am Coll Cardiol. 20:1992;578-586.
32. Tomai F., Crea F., Gaspardone A., et al. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol. 22:1993;1892-1896.
33. + channel blocker. Circulation. 90:1994;700-705.
34. 1 adenosine receptor blockade by bamifylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J. 17:1996;846-853.
35. Claeys M.J., Vrints C.J., Bosmans J.M., Conraads V.M., Snoeck J.P. Aminophylline inhibits adaptation to ischaemia during angioplasty role of adenosine in ischaemic preconditioning . Eur Heart J. 17:1996;539-544.
36. Lim R., Laskey W.K. Ischemic preconditioning in unstable coronary syndromes evidence for time dependence . J Am Coll Cardiol. 30:1997;1461-1465.
37. Sakata Y., Kodama K., Kitakaze M., et al. Different mechanisms of ischemic adaptation to repeated coronary occlusion in patients with and without recruitable collateral circulation. J Am Coll Cardiol. 30:1997;1679-1686.
38. Tomai F., Crea F., Gaspardone A., et al. Phentolamine prevents adaptation to ischemia during coronary angioplasty role of α-adrenergic receptors in ischemic preconditioning . Circulation. 96:1997;2171-2177.
39. Leesar M.A., Stoddard M., Ahmed M., Broadbent J., Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:1997;2500-2507.
40. Shattock M.J., Lawson C.S., Hearse D.J., Downey J.M. Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. J Mol Cell Cardiol. 28:1996;1339-1347.
41. Cohen M.V., Yang X.M., Downey J.M. Attenuation of ST-segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon. Basic Res Cardiol. 92:1997;426-434.
42. Leesar M., Bhatti Z., Masden R., Xenopoulos N., Bolli R. Adenosine preconditions human myocardium against the metabolic effects of ischemia during PTCA. (abstr). J Am Coll Cardiol. 29:1997;316A.
43. Stoddard M.F., Hasnie A.M.A., Leesar M., Bolli R. Adenosine preconditions against ischemia-induced systolic and diastolic dysfunction during percutaneous coronary angioplasty. (abstr). J Am Coll Cardiol. 31:1998;458A.
44. Huskisson E.C. Measurement of pain. Lancet. 2:1974;1127-1131.
45. Doucette L.W., Corl D., Payne H.M., et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery blood flow velocity. Circulation. 85:1992;1899-1911.
46. Vanyi J., Bowres T.R., Jarvisi G., White C.W. Can an intracoronary Doppler wire accurately measure changes in coronary blood flow velocity? Cathet Cardiovasc Diagn. 29:1993;240-246.
47. Bartunek J., Sys S.U., Heyndrickx G.R., Pijls N.H., De Bruyne B. Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol. 26:1995;328-334.
48. Kern M.J., Donohue T.J., Bach R.G., Aguirre F.V., Caracciolo E.A., Ofili E. Quantitating coronary flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol. 71:1993;34D-40D.
49. Assmann P.E., Slager C.J., van der Borden S.G., et al. Comparison of models for quantitative left ventricular wall-motion analysis from two-dimensional echocardiograms during acute myocardial infarction. Am J Cardiol. 71:1993;1262-1269.
50. Schiller N.B., Shah P.M., Crawford M., et al. Recommendation for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
51. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
52. Bolli R., Leesar M., Ahmed M., Stoddard M., Broadbent J. Letter to the Editor. Circulation. 98:1998;824-825.
53. Billinger M., Fleisch M., Eberli F.R., Garachemani A., Meier B., Seiler C. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol. 33:1999;1027-1035.
54. Kyriakidis M.K., Petropoulakis P.N., Tentolouris C.A., et al. Relation between changes in blood flow of the contralateral coronary artery and the angiographic extent and function of recruitable collateral vessels arising from this artery during balloon coronary occlusion. J Am Coll Cardiol. 23:1994;869-878.
55. Parratt J.R., Vegh A., Zeitlin J., et al. Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. Am J Cardiol. 80:1997;124A-131A.